HES-200 30 g/ 4.5 g (130/0.4) per 500 mL Solution for Injection (IV) Filipines - anglès - FDA (Food And Drug Administration)

hes-200 30 g/ 4.5 g (130/0.4) per 500 ml solution for injection (iv)

endure medical, inc.; distributor: endure medical, inc. - hydroxyethyl starch 130/0.4, sodium chloride. - solution for injection (iv) - 30 g/ 4.5 g (130/0.4) per 500 ml

HES-130 15 g/ 2.25 g (130/0.4) per 250 mL Solution for Injection (IV) Filipines - anglès - FDA (Food And Drug Administration)

hes-130 15 g/ 2.25 g (130/0.4) per 250 ml solution for injection (iv)

endure medical, inc.; distributor: endure medical, inc. - hydroxyethyl starch 130/0.4, sodium chloride - solution for injection (iv) - 15 g/ 2.25 g (130/0.4) per 250 ml

Meropenem Kabi meropenem (as trihydrate) 1 g Powder for Injection Vials Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

meropenem kabi meropenem (as trihydrate) 1 g powder for injection vials

fresenius kabi australia pty ltd - meropenem trihydrate, quantity: 1140 mg (equivalent: meropenem, qty 1000 mg) - injection, powder for - excipient ingredients: sodium carbonate - indications,meropenem kabi is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,? community acquired lower respiratory tract infection ,? hospital acquired lower respiratory tract infection,? complicated urinary tract infection,? febrile neutropaenia,? intra-abdominal and gynaecological (poly microbial) infections,? complicated skin and skin structure infections,? meningitis,? septicaemia

Meropenem Kabi meropenem (as trihydrate) 500 mg Powder for Injection Vials Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

meropenem kabi meropenem (as trihydrate) 500 mg powder for injection vials

fresenius kabi australia pty ltd - meropenem trihydrate, quantity: 570 mg (equivalent: meropenem, qty 500 mg) - injection, powder for - excipient ingredients: sodium carbonate - indications,meropenem kabi is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,? community acquired lower respiratory tract infection ,? hospital acquired lower respiratory tract infection,? complicated urinary tract infection,? febrile neutropaenia,? intra-abdominal and gynaecological (poly microbial) infections,? complicated skin and skin structure infections,? meningitis,? septicaemia

HEMOHES 10% 10% %w/v Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

hemohes 10% 10% %w/v solution for infusion

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - 10% %w/v

HEMOHES 6% 6% %w/v Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

hemohes 6% 6% %w/v solution for infusion

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - 6% %w/v

HYPERHAES %v/v Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

hyperhaes %v/v solution for infusion

fresenius kabi limited - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - %v/v

INFUKOLL N 6% Per Cent Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

infukoll n 6% per cent solution for infusion

serumwerk bernburg ag - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - 6% per cent

INFUKOLL N 6 Per Cent Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

infukoll n 6 per cent solution for infusion

serumwerk bernburg ag - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - 6 per cent

VENOFUNDIN 6 %w/w Solution for Infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

venofundin 6 %w/w solution for infusion

b. braun melsungen ag - poly(o-2-hydroxyethyl)starch sodium chloride - solution for infusion - 6 %w/w